Nektar Therapeutics has grown revenue −14% a year over three years and −15% a year over five. Revenue growth, 3-year annual rate: −14% (Biotechnology median +21%). Revenue growth, 5-year rate: −15%, growth has picked up over the last three years. Years of annual history on file: 17, FY2009 to FY2025, as filed.

NKTRNektar Therapeutics

HealthcareUSD

$73.85

$22.4752 weeks$100.35

Is it growing?

Is NKTR growing?

Nektar Therapeutics has grown revenue −14% a year over three years and −15% a year over five.

−14%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −15%
Revenue growth, 5-year rate · −14% over three · growth has picked up over the last three years
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›